Senthil Sundaram
2021
In 2021, Senthil Sundaram earned a total compensation of $3.1M as Chief Executive Officer at Terns Pharmaceuticals, a 77% decrease compared to previous year.
Compensation breakdown
| Bonus | $38,531 |
|---|---|
| Non-Equity Incentive Plan | $295,407 |
| Option Awards | $2,276,091 |
| Salary | $513,750 |
| Other | $2,516 |
| Total | $3,126,295 |
Sundaram received $2.3M in option awards, accounting for 73% of the total pay in 2021.
Sundaram also received $38.5K in bonus, $295.4K in non-equity incentive plan, $513.8K in salary and $2.5K in other compensation.
Rankings
In 2021, Senthil Sundaram's compensation ranked 4,273rd out of 12,415 executives tracked by ExecPay. In other words, Sundaram earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,273 out of 12,415 | 66th |
Division Manufacturing | 1,761 out of 5,508 | 68th |
Major group Chemicals And Allied Products | 738 out of 2,378 | 69th |
Industry group Drugs | 659 out of 2,099 | 69th |
Industry Pharmaceutical Preparations | 467 out of 1,549 | 70th |
Source: SEC filing on April 29, 2022.
Sundaram's colleagues
We found two more compensation records of executives who worked with Senthil Sundaram at Terns Pharmaceuticals in 2021.